|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Loss on impairment of assets | |||||
| Loss on sale of assets | |||||
| Impairment of intangible assets | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other (expense) income | |||||
| Change in valuation of contingent consideration | |||||
| Interest expense, net | |||||
| Liquidated damages | |||||
| Total other expense | |||||
| Income (loss) before income taxes | |||||
| Income tax provision | |||||
| Loss from continuing operations | |||||
| Income (loss) from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Basic net income (loss) per common share (Note 2): | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic net income (loss) per common share (in dollars per share) | |||||
| Diluted net income (loss) per common share (Note 2): | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Diluted net income (loss) per common share (in dollars per share) | |||||
| Weighted average number of common shares outstanding (Note 2): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...